1Ferrara N,Henzel WJ.Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells[J].Biochem Biophys Res Commun,1989,161:851
6Soker S,Takashima S,Miao HQ,et al.Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor[J].Cell,1998,92:735
7Yuan L,Moyon D,Pardanaud L,et al.Abnormal lymphatic vessel development in neuropilin 2 mutant mice[J].Development,2002,129:4797
8Schaper W,Buschmann I.VEGF and therapeutic opportunities in cardiovascular diseases[J].Curr Opin Biotechnol,1999,10(6):541
9Levy AP,Levy NS,Wegner S,et al.Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia[J].J Biol Chem,1995,270(22):13333
10Muher ER,Kaelin WG Jr.von Hippel-Lindau disease[J].Medicine(Baltimore),1997,76:381
2Oh SJ. VEGF and VEGF C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane[J]. Dev Biol,1997, 188:96.
3Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nat Med, 2001,7(2) :193.
4He Y, Kozaki K, Karpanen T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling[J]. Nail Cancer Inst, 2002, 94(11):819.
5He Y, Karpanen T, Alitalo, el al. Role of lymphangiogenic factors in tumor metastasis[J]. Biochimica Biophysica Acta, 2004,1654(1) :3.
6Sergio D, Margaret C, Kari A, et al. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy[J]. Blood, 2002, 99(6) :2179.
7Masakazu O, Takeshi N, Yukihiro K, et al. Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer [J]. Oncol Rep,2003, 10(8) :939.
8Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication[J]. Semin Diagn Pathol,1993,10(2):302.
9Hanrahan V, Currie MJ,Gunningham SP, et al. The angiogenic switch for vascular endothelial growth factor(VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression[J].J Pathol, 2003,200(2) :183.
10George MI., Tutton MG, Janssen F, et al, VEGF-A,VEGF-C, and VEGF-D in colorectal cancer progression[J]. Neoplasia, 2001,3(5) :420.
6Sato Y. Update on endogenous inhibitors of angiogenesis [J]. Endothelium, 2006,13:147.
7Watanabe K, Hasegawa Y, Yamashita H, et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis[J]. J Clin Invest, 2004,114 : 898.
8Shibuya T, Watanabe K, Yamashita H, et al. Isolation and characterization of vasohibin-2 as a homologue of VEGF- inducible endothelium-derived angiogenesis inhibitor vasohibin[J]. Arterioscler Thromb Vase Biol,2006,26 : 1051.
9Abe M,Sato Y. cDNA mieroarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells[J]. Angiogenesis, 2001,4 : 289.
10Shimizu K, Watanabe K, Yamashita H, et al. Gene regulation of a novel angiogenesis inhibitor,vasohibin,in endothelial cells[J].Biochem Biophys Res Commun, 2005, 327:700.
